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Abstract
Protein kinases C (PKCs) and extracellular signal-regulated kinases (ERKs) are evolutionary conserved cell signalling enzymes
that coordinate cell function. Here we have employed biochemical approaches using ‘smart’ antibodies and functional
screening to unravel the importance of these enzymes to Schistosoma mansoni physiology. Various PKC and ERK isotypes
were detected, and were differentially phosphorylated (activated) throughout the various S. mansoni life stages, suggesting
isotype-specific roles and differences in signalling complexity during parasite development. Functional kinase mapping in
adult worms revealed that activated PKC and ERK were particularly associated with the adult male tegument, musculature
and oesophagus and occasionally with the oesophageal gland; other structures possessing detectable activated PKC and/or
ERK included the Mehlis’ gland, ootype, lumen of the vitellaria, seminal receptacle and excretory ducts. Pharmacological
modulation of PKC and ERK activity in adult worms using GF109203X, U0126, or PMA, resulted in significant physiological
disturbance commensurate with these proteins occupying a central position in signalling pathways associated with
schistosome muscular activity, neuromuscular coordination, reproductive function, attachment and pairing. Increased
activation of ERK and PKC was also detected in worms following praziquantel treatment, with increased signalling
associated with the tegument and excretory system and activated ERK localizing to previously unseen structures, including
the cephalic ganglia. These findings support roles for PKC and ERK in S. mansoni homeostasis, and identify these kinase
groups as potential targets for chemotherapeutic treatments against human schistosomiasis, a neglected tropical disease of
enormous public health significance.
Citation: Ressurreic¸a˜o M, De Saram P, Kirk RS, Rollinson D, Emery AM, et al. (2014) Protein Kinase C and Extracellular Signal-Regulated Kinase Regulate Movement,
Attachment, Pairing and Egg Release in Schistosoma mansoni. PLoS Negl Trop Dis 8(6): e2924. doi:10.1371/journal.pntd.0002924
Editor: Robin B. Gasser, University of Melbourne, Australia
Received November 4, 2013; Accepted April 19, 2014; Published June 12, 2014
Copyright:  2014 Ressurreic¸a˜o et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was financially supported by Kingston University (www.kingston.ac.uk) and the Natural History Museum, London (www.nhm.ac.uk) through
core funding; there was no specific project grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: t.walker@kingston.ac.uk
Introduction
Protein kinases C (PKCs) and extracellular signal-regulated
kinases/mitogen-activated protein kinases (ERKs/MAPKs) are
signalling enzymes that play a critical role in regulating cellular
processes, such as gene expression, the cell cycle, growth,
development and differentiation, cellular motility, survival and
apoptosis [1,2]. PKC/ERK signalling occurs in response to
various stimuli, including ligands that bind receptor tyrosine
kinases (RTKs) and G-protein coupled receptors (GPCRs) [1,2].
Putative PKCs and ERKs exist in kinomes of the blood flukes
Schistosoma mansoni [3,4], S. japonicum [5] and S. haematobium [6].
These parasites cause human schistosomiasis, a neglected tropical
disease (NTD) characterised by inflammatory granulomatous
reactions in the host organs that occur in response to entrapped
eggs from adult female worms [7]. The global significance of
human schistosomiasis is huge; more than 200 million people have
the disease, and 0.8 billion are at risk of infection [8,9].
Chemotherapy relies upon praziquantel (PZQ) treatment, but this
compound kills adult worms and not juvenile stages, and does not
prevent re-infection [10,11]; emergence of drug resistant
strains is also possible [12]. Although anti-schistosome vaccine
targets exist [13], some worms exhibit antigenic polymor-
phism, making targeting difficult [14]. Thus, there is consid-
erable interest in identifying new anti-schistosome drug targets,
and the protein kinases are potential candidate molecules
[15,16].
In humans 10 PKCs exist, including PKCbI and PKCbII, which
arise from alternate gene splicing [17]. PKCs comprise a C-
terminal serine/threonine kinase domain linked through a flexible
hinge segment to an N-terminal regulatory region that contains
diacylglycerol (DAG)-sensitive and Ca2+-sensitive domains [18].
Conventional PKCs (cPKCs: PKCa, PKCbI/bII, and PKCc) are
DAG sensitive and Ca2+ responsive; novel PKCs (nPKCs: PKCd,
PKCe, PKCg, and PKCh) are DAG sensitive but Ca2+ insensitive;
and atypical PKCs (aPKCs: PKCf and PKCi, or l-murine) are
insensitive to both DAG and Ca2+ [18]. Phosphorylation on
specific amino acid residues is also crucial to PKC activation [19].
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Previously, a DAG/Ca2+-dependent PKC-like activity and a
phospholipid/phorbol ester sensitive kinase activity were detected
in adult S. mansoni homogenates [20,21], and a PKC (SmPKC1)
homologous to human PKCb was characterised molecularly [22].
Previously, we identified four putative PKCs in the S. mansoni
genome with homology to human PKCs, particularly within
functional domains [23]; two proteins were similar to human
cPKCbI, one to nPKCe and one to aPKCf [23], with PKCe also
being designated PKCg [4]. Using phospho-specific antibodies,
we showed that activated PKCb associated with the neural mass,
tegument, ciliated plates and germinal cells of miracidia, and that
PKC activation restricted development to mother sporocysts that
parasitize the snail intermediate host [23].
MAPK pathways exist in all eukaryotes, with components being
conserved among yeast, invertebrates and mammals [24–29]. The
ERK pathway features Ras as a monomeric G-protein, Raf as a
MAPKKK, MAPK/ERK Kinase (MEK) as a MAPKK, and
ERK as a MAPK, the last three forming a hierarchical kinase
cascade [30]. Humans and many other organisms express ERK1
and ERK2 (p44 and p42 MAPK) to varying extents in tissues and
more than 150 ERK1/2 substrates exist [2], including cytosolic,
membrane, nuclear and cytoskeletal proteins [30]. Phosphoryla-
tion of ERK1/2 on threonine and tyrosine resides within the Thr-
Glu-Tyr (TEY) motif in the activation loop is essential for
activation. In S. mansoni, Ras GTPase activator protein- (Ras-GAP)
and ERK1/2-like proteins have been detected [31], and a Ras
homologue has been characterised [32]. Activation of the S. mansoni
epidermal growth factor receptor (EGFR; SER) by human EGF
leads to ERK2 phosphorylation in Xenopus oocytes [33], and
hypothetical ERK pathways for S. mansoni and S. japonicum have
been reconstructed in silico [3,4,34], supporting that ERK
signalling is intact in schistosomes.
Identifying signalling molecules that play a fundamental role in
cellular communication and function of schistosomes represents
one of the great challenges of the schistosome post-genomic era
[16]. The aims of the current study were to characterise global
PKC and ERK signalling in S. mansoni and to determine whether
PKC and ERK are critical to schistosome function. We
demonstrated several PKC and ERK isotypes, profiling activities
in different life-stages. We determined PKC and ERK responses to
kinase activators and inhibitors in adult worms, and determined
the localization of active kinases in intact worms in situ through
functional kinase mapping. Finally, we showed physiological roles
for PKC and ERK in schistosomes through the modulation of
kinase activities using pharmacological agents. The findings,
together with those also presented for the effects of PZQ on
PKC/ERK signalling, establish a role for PKC and ERK in worm
homeostasis and behaviour, and identify these kinase groups as
potential anti-schistosome drug targets.
Materials and Methods
Ethics statement
Laboratory animal use was within a designated facility,
regulated under the terms of the UK Animals (Scientific
Procedures) Act, 1986, complying with all requirements therein;
regular independent Home Office inspections occurred. The
Natural History Museum Ethical Review Board approved
experiments involving mice and work was carried out under
Home Office project license 70/6834.
Antibodies and reagents
Anti-phospho antibodies (Ab) used to detect phosphorylated
PKC and ERK in S. mansoni were anti-phospho-PKC (pan) (bII
Ser660) rabbit Ab (#9371), anti-phospho-PKC (pan) (f Thr410)
(190D10) rabbit mAb (#2060), immobilized anti-phospho p44/
p42 MAPK (ERK1/2) (Thr202/Tyr204) (D13.14.4E) XP rabbit
mAb (#3510), and anti-phospho-p44/42 MAPK (ERK1/2)
(Thr202/Tyr204) rabbit mAb (#9101) (Cell Signalling Technol-
ogy, New England Biolabs). The p44/p42 MAPK (ERK1/2) (non-
radioactive) immunoprecipitation/kinase assay kit, phorbol 12-
myristate 13-acetate (PMA), cell lysis buffer, RIPA buffer, lambda
phosphatase, and anti-rabbit horseradish peroxidase (HRP)-linked
secondary antibodies were also purchased from Cell Signalling
Technology. The Omnia S/T peptide 8 kinase assay kit
(KNZ1081), RPMI-1640 medium, foetal bovine serum, antibiot-
ics/antimycotics, and anti-rabbit Alexa Fluor 488 secondary
antibodies were purchased from Invitrogen. Pre-cast Precise
10% polyacrylamide gels, West Pico chemiluminescence substrate,
Restore Western blot stripping buffer and Halt protease/
phosphatase inhibitor cocktail were from Pierce, whereas nitro-
cellulose membrane was from GE Health. U0126, GF109203X,
and PKC catalytic subunit derived from rat brain were purchased
from Merck. Vectashield mounting medium was from Vector
Laboratories.
Bioinformatic characterisation of S. mansoni PKCs and
ERKs
PKC and ERK gene candidates were identified from the S.
mansoni genome assembly, relying on existing annotations (http://
www.genedb.org/genedb/smansoni), Andrade et al. [4], and our
existing analysis [23]. Protein sequences were assessed for
similarity with other organisms using pBLAST (http://www.
uniprot.org). The detection site of the anti-phospho antibodies was
identified within the putative S. mansoni PKC and ERK sequences
and was aligned to human PKC and ERKs using MUSCLE
(www.ebi.ac.uk/Tools/msa/muscle).
Isolation of schistosomes
The Belo Horizonte strain of S. mansoni was maintained in
Biomphalaria glabrata and albino female mice (BKW strain).
Miracidia and in vitro transformed sporocysts were collected,
concentrated, and processed for Western blotting as previously
described [35,36]. Briefly, cercariae were collected after they
Author Summary
Parasitic blood flukes, also called schistosomes, cause
human schistosomiasis, a neglected tropical disease and
major public health problem in developing countries,
especially sub-Saharan Africa. Sustainable control of
schistosomiasis is difficult, mainly because the complex
life cycle of the parasite involves a freshwater snail host,
and the ability of the parasite to evade the immune
response of the human host and to survive for many years.
Little is yet known about the cellular mechanisms in
schistosomes and how they regulate parasite homeostasis,
development and behaviour. In this paper, the nature of
intracellular signalling by protein kinases C (PKCs) and
extracellular signal-regulated kinases (ERKs) in schisto-
somes is studied and these proteins are found to be vital
for the coordination of processes fundamental to parasite
survival, such as muscular activity and reproductive
function. Our results contribute to an understanding of
molecular events regulating schistosome function and
identify PKCs and ERKs as possible targets for the
development of new chemotherapeutic treatments
against schistosomiasis.
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emerged from patent snails and were transferred to 15 ml conical
tubes and cooled on ice for 15 min prior to centrifugation (2006
g). Concentrated cercariae were transferred to 1.5 ml microfuge
tubes, pelleted by pulse centrifugation, and homogenized on ice in
25 ml RIPA buffer containing Halt protease/phosphatase inhib-
itors. An aliquot was removed for protein quantification (Bradford
assay with Bovine serum albumin (BSA) as protein standard), 56
SDS-PAGE sample buffer added and samples heated at 95uC for
5 min. Extracts were then either electrophoresed immediately or
stored at 280uC. Adult worms were collected by hepatic portal
perfusion of mice 40–42 days post infection and were gently
washed with pre-warmed RPMI 1640 and either frozen in liquid
nitrogen and stored at 280uC for immunoprecipitation/kinase
assay, fixed on ice in acetone and stored at 4uC for immunohis-
tochemistry, or placed in RPMI 1640 at 37uC.
Exposure of adult S. mansoni to GF109203X, U0126 or
PMA to assess effects on kinase phosphorylation
Following equilibration at 37uC for 30 min in RPMI 1640, live
adult worms were treated for various durations (0, 15, 30, 60, or
120 min) with either 20 mM GF109203X, 1 mM PMA, 1 mM
U0126, dimethyl sulphoxide (DMSO; vehicle for PMA or U0126,
0.2% or 0.1%, respectively), or were left untreated (RPMI 1640
only). In addition, live adult worms were also incubated in 1 mM
PMA or DMSO for 24 h at 37uC/5% CO2 in RPMI containing
glutamine, glucose, antibiotic/antimycotic mixture (100 U peni-
cillin, 100 mg streptomycin and 0.25 mg amphotericin B/ml) and
10% FBS. GF109203X is a PKC inhibitor that competes for the
ATP binding site and therefore only catalytically inactive proteins
are inhibited. The effect of GF109203X on PKC was thus
established by pre-incubating worms in 20 mM GF109203X or
RPMI 1640 for 120 min prior to exposure to 1 mM PMA for
30 min at 37uC. The MEK inhibitor U0126 inhibits active and
inactive MEK1/2 blocking ERK phosphorylation. Immediately
after treatment, medium was removed and worms were either
homogenized in 30 ml RIPA buffer and processed for Western
blotting or were acetone-fixed for immunohistochemistry in
similar ways to that for cercariae (above).
S. mansoni PKC and ERK immunoprecipitation and kinase
activity assay
Perfused adult worms (100 or 20 pairs for PKC or ERK assay,
respectively) were transferred to microfuge tubes and washed twice
with RPMI 1640 at 37uC. Worms were then exposed to 1 mM
PMA or DMSO (vehicle) in RPMI 1640 for 30 min at 37uC prior
to being snap frozen in liquid nitrogen and stored at 280uC.
When required, worm pairs were defrosted and homogenized on
ice in 100 ml cell lysis buffer with Halt protease/phosphatase
inhibitor cocktail. The homogenate was then centrifuged for
15 min at 4uC, the supernatant recovered, and the remaining
pellet re-homogenized in 50 ml cell lysis buffer with inhibitors and
centrifuged for a further 10 min. Supernatants were pooled and
equal quantities of protein from each sample incubated overnight
at 4uC in either anti-phospho PKC (pan) (f Thr410), anti-phospho
PKC (pan) (bII Ser660) antibodies, or immobilized anti-phospho
p44/p42 MAPK (ERK1/2) (Thr202/Tyr204) (D13.14.4E) XP
primary antibodies (each at 1/25 dilution). The next day, 50 ml
protein A agarose beads were added to homogenates and agitated
for 5 min at 4uC except when the pre-immobilized anti-phospho
p44/p42 MAPK (ERK1/2) antibody was used; such rapid
immunocapture reduces non-specific binding while permitting
efficient immunocomplex adsorption [35,37]. Following brief
centrifugation, samples were washed twice each in 500 ml ice-cold
lysis buffer and 500 ml ice-cold kinase buffer (25 mM Tris
(pH 7.5), 5 mM b-glycerolphosphate, 2 mM DTT, 0.1 mM
Na3VO4 and 10 mM MgCl2). Negative control immunoprecipi-
tations lacking primary antibodies were also performed.
The Omnia (Ser/Thr 8 peptide) PKC assay was performed as
per the manufacturer’s instructions to detect immunoprecipitated
PKC activity. Master mix, containing ATP, Ser/Thr 8 substrate,
DTT, kinase buffer and water was added to individual wells of
black 96-well microtitre plates (Nunc) and reactions started by
adding immunocomplex. Accumulation of phosphorylated sub-
strate was measured (excitation 355 nm, emission 460 nm) every
30 s for up to 200 min at 30uC using a FLUOstar OPTIMA
(BMG Labtech) microplate reader. Positive control reactions
contained 2 ng recombinant human PKC; negative controls either
lacked the substrate or comprised samples prepared without the
immunoprecipitation antibody. Immunoprecipitated ERK activity
was detected using the p44/p42 MAPK (ERK1/2) assay kit.
Immunocomplexes were re-suspended in 20 ml kinase buffer
supplemented with 200 mM ATP and 2 mg Elk-1 fusion protein
and incubated for 30 min at 30uC. Reactions were terminated
with 10 ml 36 SDS-PAGE sample buffer and samples heated at
95uC for 5 min in preparation for SDS-PAGE and Western
blotting with anti-phospho Elk-1 antibodies to reveal ERK1/2
activity. Negative controls comprised samples without immuno-
precipitation antibody.
In vitro culture of adult S. mansoni with GF109203X,
U0126 or PMA
Adult worms were placed in individual wells of a 24-well culture
plate (Nunc; 3–6 worm pairs per well) in 1.5 ml RPMI 1640
containing glutamine, glucose, antibiotic/antimycotic mixture and
10% FBS at 37uC/5% CO2 [22] for 1 h to equilibrate. To
determine effects of PKC inhibition/activation or ERK inhibition
on adult worms, 1 mM, 5 mM, 20 mM or 50 mM GF109203X or
U0126, or 1 mM PMA were added to cultures. Control groups
containing RPMI 1640 only or 0.5% DMSO (vehicle for PMA/
U0126) were also included and all media and components were
replenished daily. Worms were observed at various times over
96 h using an Olympus SZ54045 binocular dissecting microscope
and avi-format movies captured using a JVC TK-1481 composite
colour video camera linked to Studio Launcher Plus for Windows
software. Worm behaviour including pairing status and ventral
sucker attachment to the base of the culture plate was determined.
Egg release by worms was also enumerated. Detailed analysis of
worm movement was done using image J [38] (http://rsbweb.nih.
gov/ij/); the diameter of the well in pixels was calibrated to mm
and the distance travelled by the posterior tip of each worm in 10 s
was manually tracked and measured enabling translation into
speed of movement (velocity) of pixels/s to mm/s. Worm coiling
(Figure 10A) was determined by counting the number of coils that
persisted during 10 s visualization. Results are representative of
four independent experiments with a minimum of three replicates
each; 30 or more parasites per treatment were scored, except for
DMSO controls (n = 24).
Effect of praziquantel on adult S. mansoni PKC and ERK
phosphorylation
Racemic PZQ powder (Shin Poong Pharmaceutical) was
dissolved in DMSO. Freshly perfused adult worm pairs were
incubated in RPMI 1640 containing 0.2 mg/ml PZQ, 0.1%
DMSO (vehicle), or RPMI 1640 alone at 37uC for 15, 30 or
120 min. Next, worms were either processed for Western
blotting or immunohistochemistry as detailed above. The final
PKC and ERK in S. mansoni
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concentration of PZQ used was similar to a study [39] that
reported 0.2 mg/ml PZQ to be the lowest concentration needed to
induce maximal muscular contraction in worms, a phenotype
observed with PZQ treatment.
SDS-PAGE and western blotting
Equal amounts of sample protein (12 mg) were separated on
10% Precise SDS–PAGE gels, semi-dry transferred to nitrocellu-
lose membranes and stained with Ponceau S to confirm
homogeneous transfer. After blocking for 1 h in 5% non-fat dried
milk, membranes were washed three times in 0.1% Tween-Tris-
buffered saline (TTBS) and incubated in anti-phospho PKC (pan)
(f Thr410), anti-phospho PKC (pan) (bII Ser660) or anti-phospho
p44/p42 MAPK (ERK1/2) (Thr202/Tyr204) antibodies (1:1000
in TTBS) overnight at 4uC. After TTBS wash, blots were
incubated for 2 h at room temperature with HRP-conjugated
secondary antibodies (1:3000 in TTBS) and exposed to West Pico
chemiluminescence substrate. Immunoreactive bands were visu-
alized with a GeneGnome imaging system (Syngene) and relative
band intensities quantified using GeneTools software. Protein
loading was determined by incubating blots with anti-actin
antibodies (1:1000). When necessary blots were stripped with
Restore Western blot stripping buffer and incubated in an
alternative antibody. In addition, to confirm that the anti-phospho
PKC and anti-phospho ERK antibodies detected only the
phosphorylated kinases, blots were treated with lambda phospha-
tase (400 U/ml in TTBS containing 1% BSA and 2 mM MnCl2)
for 4 h before incubation in primary antibodies; secondary
antibody labeling and detection were then performed.
Immunohistochemistry
Acetone-fixed worms were washed twice with PBS, treated with
100 mM glycine for 15 min and blocked in 10% goat serum for
1 h. After a further wash, worms were incubated in anti-phospho
PKC (pan) (f Thr410), anti-phospho PKC (pan) (bII Ser660) or
anti-phospho p44/p42 MAPK (ERK1/2) (Thr202/Tyr204) anti-
bodies (1:50 dilution in PBS with 5% BSA) for 3 days on a rotator.
Worms were then washed twice in PBS for 1 h each and incubated
in Alexa Fluor 488 secondary antibodies (1:500 in 5% BSA) and
2 mg/ml rhodamine phalloidin for 24 h followed by two 1 h
washes in PBS. Next, specimens were mounted on slides in
Vectashield. All incubations were carried out at room temperature
and washes were done in microfuge tubes. Adult worms were
visualized on a Leica TCS SP2 AOBS confocal laser scanning
microscope using 206 dry, 406 or 626 oil immersion objectives
and images captured. The signal received from negative controls
(i.e. worms incubated with secondary antibody only) was negated
from that of the positive samples. This was achieved by reducing
the power level of the photomultiplier tube, which was then kept
constant for all observations.
Statistical analysis
Statistical comparisons were performed with one-way analysis of
variance (ANOVA) using Minitab (version 16). All data were
expressed as mean 6SEM, and statistical significance was
determined by a Fisher’s multiple pair-wise comparison.
Results/Discussion
Phosphorylated PKC- and ERK-like proteins in S. mansoni
life stages
The phospho-specific antibodies used in this study were anti-
phospho PKC (pan) (f Thr410), anti-phospho PKC (pan) (bII
Ser660) and anti-phospho p44/p42 MAPK (ERK1/2) (Thr202/
Tyr204). Using the S. mansoni genome, four putative PKCs [23]
and five putative ERKs displaying homology to human isotypes
were identified from full-length sequences. Comparative analysis
revealed that, except for Smp_131700 (,95 kDa PKC), the
antibody recognition sequence was conserved in the putative
PKCs and ERK1/2, with the key phosphorylation motif retained;
similar levels of sequence homology exist between the human
isotypes recognized by these antibodies (Figure 1). Such motif
conservation is common, because of the critical nature of the
phosphorylation site in activation of the respective kinases
[1,2,18,40]. As with human PKCs, in S. mansoni, the sequence
surrounding the phosphorylated Thr residue within the PDK1
consensus motif was more conserved than that surrounding the
Ser phosphorylation site in the bulky ring motif (Figure 1).
These antibodies were then used to detect phosphorylated
(activated) PKCs and ERK1/2 in homogenates (12 mg protein) of
four different life stages (miracidium, sporocyst, cercaria and adult
worm) of S. mansoni by Western blotting. The anti-phospho PKC
(pan) (f Thr410) antibodies have been used previously to detect
activated PKCs in invertebrates other than S. mansoni (e.g. [41]).
They detect PKCa, bI, bII, c, d, e, g, h, and f/i isotypes only
when phosphorylated at a site homologous to Thr410 of human
PKCf (Figure 1) that is critical to catalytic competency and PKC
activation [42]. In adult worms and cercariae, three immunore-
active bands were consistently detected, namely an,78/,81 kDa
doublet and a ,132 kDa band with greater immunoreactivity in
adult males than cercariae (Figure 2A). A weak band was also seen
just above the ,132 kDa band; however, this was not quantified
in later experiments with worm pairs, as it was not always evident.
Occasionally, a weak immunoreactive band was also detected at
,116 kDa in male worms and worm pairs (Figure 2A). In
sporocysts and miracidia, a single ,81 kDa band was detected
which appeared highly phosphorylated in sporocysts compared to
the other life stages studied (Figure 2A).
Previously, we validated anti-phospho PKC (pan) (bII Ser660)
antibodies to detect phosphorylated (activated) PKC in S. mansoni
miracidia and sporocysts [23]; they have also been used on other
invertebrates, such as the snail Lymnaea stagnalis [43,44]. These
antibodies recognize PKCa, bI, bII, d, e, g, and h isotypes only
when phosphorylated at a residue homologous to Ser660 of
human PKCbII (Figure 1) that is crucial to activation [45]. Anti-
phospho PKC (pan) (bII Ser660) antibodies detected up to three
immunoreactive bands in homogenates of adult S. mansoni
(Figure 2B). Two faint bands were observed at ,78 kDa and
,132 kDa, similar to with anti-phospho PKC (pan) (f Thr410)
antibodies; in addition, a more immunoreactive band of
,116 kDa was seen, occasionally also detected with anti-phospho
PKC (pan) (f Thr410) antibodies. This ,116 kDa protein was
only detected in cercariae and adult worms, with greater
immunoreactivity in worm pairs (Figure 2B). No immunoreactive
proteins were detected in sporocyst homogenates with anti-
phospho PKC (pan) (Ser660) antibodies, and in miracidia only
one protein was detected (,78 kDa) (Figure 2B). This finding is in
accord with our previously published work that demonstrated that
this PKC became inactive during the miracidium-to-mother-
sporocyst transition [23].
Finally, anti-phospho p44/42 MAPK (ERK1/2) (Thr202/
Tyr204) antibodies have been used extensively to detect ERK
phosphorylation (activation) in invertebrates including flies, snails
and nematodes [44,46–49], but not in S. mansoni. These antibodies
detect ERK1/2 when phosphorylated at residues homologous to
Thr202/Tyr204 of human ERK1 (Figure 1) with phosphorylation
critical to activation. Three proteins were detected using these
antibodies across the four life stages of S. mansoni investigated
PKC and ERK in S. mansoni
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(Figure 2C). Proteins of ,48 kDa and ,43 kDa were detected in
adult worm homogenates, with greater immunoreactivity consis-
tently observed in males. In cercariae and sporocysts, a ,43 kDa
band and a weaker ,38 kDa band were evident but the ,48 kDa
protein was not seen. The ,43 kDa band was more intense in
sporocysts than in cercariae, female worms or adult worm pairs
(Figure 2C). Strikingly, there were no visible immunoreactive
ERKs in miracidia homogenates (Figure 2C), when probing equal
protein amounts from each life stage.
Treatment of blots containing protein extracts (20 mg) of
adult worm pairs with lambda phosphatase for 4 h prior to
exposure to each of the anti-phospho antibodies resulted in
either a total loss (Figures 2B, 2C) or substantial reduction
(Figure 2A) in immunoreactivity, demonstrating that the
antibodies react specifically with the phosphorylated forms of
these proteins.
Immunodetected ERK- and PKC-like proteins from S.
mansoni have characteristic ERK and PKC activities
Next, we determined whether the phosphorylation (activation)
state of the bands detected with the anti-phospho-PKC antibodies
could be modulated using the PKC activator PMA or inhibitor
GF109203X, reagents that we used previously to characterise
PKC signalling in S. mansoni miracidia [23] and L. stagnalis
haemocytes [49]. Phosphorylation of all bands increased signifi-
cantly (p#0.05) when live adult worms were exposed to 1 mM
PMA for 30 min (Figure 3A), demonstrating that the endogenous
PKC-like proteins are not fully activated in adults under
physiological conditions. The ,116 kDa and ,132 kDa proteins
showed the greatest increases in phosphorylation and are therefore
likely cPKCs, which are characteristically highly responsive to
DAG, Ca2+ and phorbol esters such as PMA [19]. A biphasic
effect of PMA on PKC phosphorylation was also evident with
increased phosphorylation observed between 15 and 30 min,
followed by a decrease to basal levels at 60 min increasing again at
120 min (data not shown). GF109203X inhibits PKC activity via
competition with the ATP binding site and does not directly
inhibit active forms of the enzyme. Therefore, the inhibitory effect
of GF109203X on S. mansoni PKCs was assessed by pre-incubating
worms in GF109203X for 120 min, followed by exposure to 1 mM
PMA for 30 min. Under these conditions, the PMA-induced
phosphorylation of PKCs was blocked (Figure 3A). Then, to
determine whether the immunoreactive phosphoproteins pos-
sessed PKC activity an immunoprecipitation/kinase assay was
conducted. Adult worm proteins immunoprecipitated with either
anti-phospho PKC antibody were able to phosphorylate the PKC
substrate (Ser/Thr 8 peptide), with higher activity achieved with
anti-phospho PKC (pan) (f Thr410) antibodies than with anti-
phospho PKC (pan) (bII Ser660) antibodies; activity also increased
when worms were exposed to 1 mM PMA for 30 min (Figure 3B).
The differences in kinase activity, seen as a result of the different
antibodies having been used, is most likely due to the antibody
affinity towards, and access to, the various epitopes in the native
protein, together with the differential recognition of PKC isoforms
displayed in Figure 3A.
Activated MEK1/2 is known to phosphorylate ERK1/2 in the
TEY motif [30]. Therefore, to evaluate the effect of MEK
inhibition on ERK phosphorylation, live adult worms were
exposed to 1 mM of the MEK inhibitor U0126 for 30, 60 or
120 min. Immunoblotting revealed that U0126 significantly
attenuated ERK phosphorylation over time, compared to controls
(p#0.05; Figure 4A). After 30 min, phosphorylation of the
,48 kDa and ,43 kDa proteins was attenuated by ,27% and
72%, respectively (p#0.01 and p#0.001), and after 120 min ERK
phosphorylation was almost completely blocked (Figure 4A).
Furthermore, adult worm proteins immunoprecipitated with
anti-phospho p44/42 MAPK (ERK1/2) (Thr202/Tyr204) anti-
bodies phosphorylated the ERK substrate Elk-1 (Figure 4B),
Figure 1. Alignment of antibody recognition sites. Comparison
of the amino acid recognition sequences, together with the phosphor-
ylated site, for the three anti-phospho antibodies used between S.
mansoni PKC and ERK predicted protein sequences obtained from the S.
mansoni genome database and relevant human protein sequences. The
anti-phospho PKC (pan) (bII Ser660) antibodies recognize multiple
human PKCs including PKCbI, bII and e; based on sequence similarity
these antibodies are predicted to react with Smp_128480 and
Smp_176360 (both b-type PKCs) only when phosphorylated on
Ser647 and Ser590, respectively within the bulky ring motif. The S.
mansoni e-type PKC (Smp_131700) lacks the conserved Ser phosphor-
ylation site, as does i-type PKC (Smp_096310) in common with human
PKCi. The anti-phospho PKC (pan) (f Thr410) antibodies also recognize
multiple human PKCs including PKCbI, bII, e and i; based on sequence
similarity these antibodies are predicted to react with all S. mansoni
PKCs only when phosphorylated on the conserved Thr residue within
the PDK1 consensus motif. The anti-phospho p44/42 MAPK (Thr202/
Tyr204) antibodies recognize human ERK1 and ERK2 only when
phosphorylated on Thr and Tyr within the conserved TEY motif; based
on sequence similarity, these antibodies are predicted to detect S.
mansoni ERK1 and ERK 2 (Smp_142050 and Smp_047900, respectively)
when phosphorylated.
doi:10.1371/journal.pntd.0002924.g001
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demonstrating that the detected ERK proteins display ERK
activity.
Collectively these findings, when combined with knowledge of
molecular weights (below) and antibody recognition sites, are
entirely consistent with the detected proteins being S. mansoni
PKCs and ERK1/2, with MEK acting upstream of ERK as in
other organisms.
The nature of the detected S. mansoni PKC and ERK
proteins and their differential expression profiles
Having determined that the immunoreactive proteins behave
like PKCs and ERKs, it was possible to consider these proteins in
relation to the S. mansoni genome data sets. Although the precise
assignment of Smp identifiers to immunoreactive bands was
beyond the scope of this study, antibody recognition sites support a
Figure 2. Phosphorylated (activated) PKC- and ERK-like proteins exist in four different life stages of S. mansoni. Western blot showing
immunoreactive bands detected with (A) anti-phospho PKC (pan) (f Thr410), (B) anti-phospho PKC (pan) (bII Ser660), and (C) anti-phospho p44/42
MAPK (ERK1/2) (Thr202/Tyr204) antibodies (Ab) in miracidia (M), mother sporocysts (S), cercariae (C), adult female (R) and male (=) worms, and
coupled worm pairs (WP) (,12 mg for each sample). Results are representative of three independent experiments. Lambda phosphatase was also
employed to confirm that the antibodies reacted only with the phosphorylated form of each protein; actin was used a loading control.
doi:10.1371/journal.pntd.0002924.g002
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Figure 3. S. mansoni phosphorylated (activated) PKC-like proteins possess characteristic PKC activity. (A) Immunodetection of
phosphorylated (activated) S. mansoni PKC-like proteins after exposure of live adult worm pairs to GF109203X (20 mM; 2 h), GF109203X (20 mM; 2 h)
followed by PMA (1 mM; 30 min), or PMA (1 mM; 30 min) only. Protein homogenates (12 mg) were processed for Western blotting and blots probed
with anti-phospho PKC (pan) (f Thr410) or anti-phospho PKC (pan) (bII Ser660) antibodies (Ab); anti-actin antibodies were used to assess protein
loading between samples. Immunoreactive bands from three independent experiments, each with two replicates, were analyzed with GeneTools and
the mean relative change (6 SEM; see graphs) in phosphorylation for each protein calculated relative to the phosphorylation levels of untreated
(DMSO or RPMI 1640) controls that were assigned a value of 1 (shown as the dotted line). * p#0.05, ** p#0.01, and *** p#0.001 (ANOVA). (B) Adult S.
mansoni were either left untreated (upper graph) or were exposed to PMA (1 mM) for 30 min or DMSO (vehicle) (lower graph) prior to
homogenization; equal amounts of protein were then used for immunoprecipitation with anti-phospho PKC (pan) (f Thr410) or (bII Ser 660)
antibodies, or for the negative (beads only) control. The PKC activities of immunocomplexes, negative control, supernatant, and positive control
PKC and ERK in S. mansoni
PLOS Neglected Tropical Diseases | www.plosntds.org 7 June 2014 | Volume 8 | Issue 6 | e2924
tentative assignment to the PKC class (Figure S3). As we have
previously reported [23], the S. mansoni genome contains four
annotated PKCs, two similar to human cPKCbI (Smp_128480,
75.6 kDa; Smp_176360, 114.9 kDa), one to nPKCe
(Smp_131700, 94.9 kDa) and one to aPKCf/i (Smp_096310,
76.7 kDa), with PKCe also being similar to PKCg [4]. Of these
molecules, the ,78 kDa and ,116 kDa phosphorylated PKCs
detected by anti-phospho PKC (Ser 660) antibodies are most likely
the b-type cPKCs (Smp_128480 and Smp_176360), because the
crucial Ser residue recognized by these antibodies is conserved in
these Smps and because the remaining S. mansoni nPKCe/aPKCi
proteins do not possess this Ser autophosphorylation site (Figure 1).
Moreover, the ,81 kDa band detected exclusively with anti-
phospho PKC (pan) (f Thr410) antibodies most likely corresponds
to the atypical i type PKC (Smp_096310) (Figure S3) as the Thr
phosphorylation site (Thr489) is conserved but, as with human
PKCi, the Ser phosphorylation site is not (Figure 1). The lack of
strong activation of this PKC by PMA (Figure 3A) further supports
this finding, given that aPKCs do not respond directly to DAG/
PMA. Available transcriptomic data for cercariae, schistosomules
and adult worms [50] (www.genedb.org) also confirm that these
PKCs are expressed in these life stages, with expression being
developmentally regulated (cf. Figure S3). The large ,132 kDa
PKC-like protein consistently detected in adult worms and
cercariae using anti-phospho PKC (pan) (f Thr410) antibodies
was activated by PMA and inhibited by GF109203X, confirming
its PKC-like nature. Although absent from mammals, such high
molecular weight PKCs are common in ‘‘lower’’ animals and,
using similar antibodies, have been detected in the sea urchin
Lytechnus pictus (135–140 kDa) [51] and Caenorhabditis elegans
(122 kDa) [52]. PKC activation profiles were notably different
among the four life stages studied, with four, two, and one PKC
detected consistently in cercariae and adult worms, miracidia and
mother sporocysts, respectively. This information suggests more
complex roles for activated PKCs in the human host-infective/-
dependent life stages. Wiest et al. [21] found nine-fold greater total
PKC activity in adult S. mansoni than in larval stages, and it is
established that PKC expression is developmentally regulated in
(recombinant human PKC) were then determined using the Onmia PKC assay kit with Ser/Thr 8 substrate peptide. Florescence was recorded every
5 min for up to 200 min. Results are representative of two independent experiments.
doi:10.1371/journal.pntd.0002924.g003
Figure 4. S. mansoni ERK-like proteins are phosphorylated (activated) by MEK and possess characteristic ERK activity. (A) Live adult
worm pairs were exposed to 1 mM U0126 or 0.1% DMSO (control) for 30, 60 or 120 min. Protein homogenates (12 mg) were processed for Western
blotting and blots probed with anti-phospho p44/42 MAPK (ERK1/2) (Thr202/Tyr204) antibodies (Ab). Immunoreactive bands from three independent
experiments were analyzed with GeneTools and the mean relative change (6 SEM; see graph) in phosphorylation of each protein calculated relative
to the phosphorylation levels of controls that were assigned a value of 1 (shown here as the dotted line). **p#0.01 and ***p#0.001 (ANOVA). (B)
Phosphorylation of Elk-1 fusion protein by immunoprecipitated ERK. Adult worm pairs were homogenized and equal amounts of protein used for
immunoprecipitation with immobilized anti-phospho p44/42 MAPK (ERK1/2) (Thr202/Tyr204) antibodies or with beads only (negative control).
Immunocomplexes were then incubated with Elk-1 fusion protein as the ERK substrate and phosphorylated Elk-1 was detected on Western blots
using anti-phospho Elk-1 antibodies. Results are representative of two independent experiments.
doi:10.1371/journal.pntd.0002924.g004
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other invertebrates [53]. We have shown that the ,78 kDa b-type
PKC of miracidia becomes inactive during development to the
asexually reproducing, parasitic mother sporocyst stage and that
PKC activity restricts this transformation [23]. Here, using anti-
phospho (pan) (f Thr410) antibodies, we see that the ,81 kDa
PKC is substantially activated in 48 h mother sporocysts
compared to miracidia, highlighting a possible role for this PKC
in asexual reproduction and signifying the dynamic nature of PKC
activation during schistosome development.
The ,48 kDa and ,43 kDa proteins detected with anti-
phospho p44/42 MAPK antibodies likely correlate to genome
sequences Smp_142050 (45.3 kDa, 70% identity to human ERK1)
and Smp_047900 (SmERK2, 40.83 kDa, 68% identity to human
ERK1), due to molecular weight and antibody detection site
similarity (Figures 1, 2C and S3); these proteins are also expressed
in the requisite life-stages [50] (www.genedb.org) (Figure S3). The
recognition site of the p44/42 MAPK antibodies was conserved
among three other putative S. mansoni ERK-like proteins
(Smp_133490, 58.7 kDa; Smp_133500, 82.7 kDa; Smp_134260,
70 kDa), however, phosphorylated ERK-like proteins of this size
were not detected on blots. The ,38 kDa protein detected in
mother sporocysts and weakly in cercariae is possibly a non-
specific band, because ,38 kDa ERK-like proteins could not be
detected in the S. mansoni genome. The ERKs also appear
differentially activated in the different S. mansoni life stages studied
(Figure 2C), with ERK1/2 (,48/,43 kDa) detected only in adult
worms. No ERK activation was detected in miracidia, and only
the ,43 kDa ERK was phosphorylated (using 12 mg protein) in
mother sporocysts and cercariae. Thus, the ,48 kDa ERK in
male worms may play a specific role in growth and development
and/or host-interactions, particularly given that human EGF
activates EGFR in S. mansoni [33] and influences ERK signalling
and proliferation in other parasites, including Echinococcus multi-
locularis [54] and Trypanosoma cruzi [55]. The ERK pathway also
interacts with the transforming growth factor b (TGFb) pathway in
schistosomes, possibly restricting interaction of SmSmad4 with
receptor-activated Smad2 [56]. Therefore, because TGFb signal-
ling plays a part in mitotic activity, parasite development and egg
embryogenesis [57,58], ERK activity in particular cell types might
suppress TGFb signalling, with concomitant effects on develop-
ment and reproduction.
Connectivity between S. mansoni ERK and PKC signalling
Cross talk between PKC and ERK signalling, with PKC
upstream of ERK is common in many organisms, including
invertebrates such as C. elegans [59]. To determine whether ERK
and PKC signalling are connected in S. mansoni, ERK phosphor-
ylation was determined after live adult worms were exposed to
PKC modulators, and vice-versa. PMA (1 mM) increased phosphor-
ylation of the ,43 kDa ERK (p#0.05; 1.8 fold) after 30 min,
however, the ,48 kDa ERK was unaffected (Figure 5A). This
activation was blocked by treatment with GF109203X for
120 min prior to PMA stimulation, supporting ERK’s dependency
on PKC in response to PMA (Figure 5A). Treatment with
GF109203X alone did not inhibit the phosphorylation of either
ERK after 120 min incubation (Figure 5A), likely because this
inhibitor only prevents activation of inactive PKC and because
ERK may also be activated independently of PKC. On the other
hand, exposure of worms to 1 mM U0126 for 60 or 120 min
stimulated phosphorylation of the ,116 kDa PKC (p#0.05;
,1.9-fold), and of the ,132 kDa PKC after 120 min (p#0.01;
,2.5-fold) (Figure 5B). Interestingly, phosphorylation of the
78 kDa PKC was suppressed after 60 min U0126 treatment but
recovered after 120 min (Figure 5B). Collectively, these findings
imply that PKC lies upstream of ERK in S. mansoni and suggest
that complex temporally regulated feedback to PKC can occur in
response to MEK inhibition.
Activated PKC and ERK in S. mansoni adult worms is
associated with muscular, tegumental and reproductive
structures
Identifying where cell signalling pathways in S. mansoni are
predominantly activated is valuable in helping to unravel their
function. Therefore, we performed functional mapping of
phosphorylated PKC and ERK in freshly perfused, paired, intact
S. mansoni adults using our recently published approaches [60]. We
preferred this approach to in situ hybridization with gene specific
probes, because we were interested in localizing functionally active
kinases rather than protein expression per se. In all cases, negative
control worms displayed minimal background staining (Figure S1).
Staining with anti-phospho PKC (pan) (f Thr410) antibodies
revealed activated PKC associated with the tegument and
tubercles of the tegument (Figures 6A, 6D, 6F and 6G),
particularly in the central dorsal-lateral region of males where
tubercles are most prominent. In addition, activated PKC was
associated with the oesophagus (Figure 6B), oesophageal glands
(Figure 6C), and the uterus of the female in the vicinity of eggs
(Figure 6E). In males, deeper confocal scanning revealed PKC
activation in the muscle layers, neural plexus, and myocytons
(Figures 6F–H). Worms labelled with anti-phospho PKC (pan) (b
Ser660) antibodies displayed generally weaker fluorescence;
however, areas with notable PKC activation included the
oesophagus (Figure 6I), tubercles on the dorsal side of the male
(Figure 6J), and muscle layers under the tegument (Figure 6K).
Live adult worms were also exposed to 1 mM PMA for 30 min in
an attempt to identify other regions displaying PKC activation. In
these specimens, activation was evident in similar regions to those
observed without PMA treatment; however, generally more
activation was observed at the tegument surface (Figure 6L), and
evidence of tegument disruption was apparent in some specimens
in response to PMA, as has been reported by other authors [61].
Activated PKC was also found to be associated with the lumen of
the vitellaria, more extensive portions of the oesophagus and the
muscular ventral sucker (Figures 6M–O). Although, in a recent
study, the transcription of the b-type PKC-encoding gene
(Smp_176360) was found to be upregulated ,3.2 times in the
testes of adult males compared to whole worms [62], no significant
PKC activation was seen in this tissue in the current study.
In untreated male worms, ERK activation was particularly
evident in excretory tubules and flame cells (Figure 7A, 7B), the
oesophagus (Figure 7C) and tubercles of the tegument (Figure 7D).
In females, regions displaying notable ERK activation included
the seminal receptacle (Figure 7E), uterus surrounding the egg
during expulsion (Figure 7F), ootype wall and the region of Mehlis’
gland (Figures 7G–H). Upon exposure to 1 mM PMA for 30 min,
activated ERK was observed in regions similar to those of
untreated samples; however, stronger immunoreactivity was
apparent in the tegument and tubercles (Figures 7I–K). Addition-
ally, activated ERK was evident in the male ventral sucker
(Figures 7I–J), the testicular lobes (Figure 7L), and ovary
(Figure 7M), possibly due to the ,43 kDa ERK, as only this
isotype responded to PMA (Figure 5A). Interestingly, ERK1
(Smp_142050) expression was recently found to be,2.7 and,3.9
times higher in the ovary and testes of adult female and male
worms, respectively, when compared to whole worms [62].
Activated ERK has also been reported in the tegument of the
cestode T. crassiceps [63], where it is thought to interact with host
factors.
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Figure 5. Connectivity between ERK and PKC signalling in S. mansoni. Adult S. mansoni were treated with (A) GF109203X (20vM; 120 min),
PMA (1 mM; 30 min), GF109203X (20 mM; 120 min) followed by PMA (1 mM; 30 min), or DMSO (vehicle control), or with (B) U0126 (1 mM; 30, 60, and
120 min) or DMSO (vehicle control). Proteins (12 mg) were then processed for Western blotting using (A) anti-phospho p44/p42 MAPK (ERK1/2)
(Thr202/Tyr204), or (B) anti-phospho PKC (pan) (f Thr410) or anti-phospho PKC (pan) (bII Ser660) antibodies (Ab). Anti-actin antibodies were used to
assess protein loading. Immunoreactive bands from three independent experiments were analysed and quantified using GeneTools and the mean
relative change (6 SEM; see graphs) in phosphorylation for each protein calculated relative to the phosphorylation levels of untreated (DMSO or
RPMI-1640) controls that were assigned a value of 1 (shown as the dotted line). *p#0.05, **p#0.01 (ANOVA).
doi:10.1371/journal.pntd.0002924.g005
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That PKC and ERK reside within the tubercles and tegument
of S. mansoni and that cross talk many occur between these
pathways is exciting, because the tegument of schistosomes is in
constant contact with host blood. The tegument is a dynamic
structure, where considerable host interplay is expected to take
place [64]. EGFRs [65] and GPCRs [66] localize to the tegument
and could activate PKCs and ERKs, possibly in response to host
growth factors/hormones, which might influence schistosome
development/survival. Localization of activated PKC to the
musculature, neural plexus and myocytons supports a role for
PKC in motor activity. Recently, we reported that activated
protein kinase A (PKA) localizes to the central and peripheral
nervous system of S. mansoni and that PKA activation results in
hyperkinesia, demonstrating a role for PKA in neuromuscular co-
ordination [60]. Activated PKA also localizes to the tegument,
tubercles and canyons between the tubercles [60]. This finding,
coupled with results described here, supports that complex
signalling occurs at the schistosome surface. Finally, the localiza-
tion of activated PKC/ERK to the oesophageal glands/oesoph-
agus, uterus during egg expulsion, the ootype, Mehlis’ gland,
seminal receptacle and the excretory system highlights the likely
importance of these kinases to schistosome reproduction and
homeostasis. Increased pumping of the pharynx/oesophagus
muscle during C. elegans starvation is dependent on ERK activity
through PKC phosphorylation [67]. We hypothesize, therefore,
that PKC/ERK regulate pumping of the schistosome oesophagus
and that interference of these pathways may restrict blood feeding.
Pharmacological modulation of PKC and ERK activity
induces physiological disturbance in adult S. mansoni
To discover physiological roles for PKC and ERK in S. mansoni
the effects of kinase modulation on adult worm phenotype were
evaluated over 96 h. A range of inhibitor concentrations was used
with doses chosen to reflect that whole, large, worms were exposed
to each inhibitor rather than single cells. Five parameters were
quantified: separation of worm pairs, male ventral sucker
detachment (in paired and unpaired males), egg output (per
couple), speed of movement (velocity, mm/s) of the worm
posterior tip (a proxy for muscular activity), and persistent coiling.
In RPMI 1640, worms remained paired releasing 103–110 eggs/
day/couple during the first 72 h, decreasing to 93 thereafter (data
not shown). Males remained attached to culture plates during the
first 24 h and only 5–7% detached between 24 h and 96 h. The
worm posterior tip velocity of couples was 3.26 mm/s (+/2
0.33 mm/s) after 1 h increasing to 3.68 mm/s (,+/20.55 mm/s)
thereafter. Extensive and/or sustained coiling was seldom
observed. There were no significant differences between DMSO
and RPMI 1640 control groups for these parameters. Worms
displayed normal physiology (Movie S1).
In contrast, U0126, which was shown to attenuate ERK
activation, increased worm unpairing with 50 mM causing 96%
separation within 1 h (p#0.001) (Figure 8A; Movies S2 and S3).
This coincided with rapid detachment of males from culture plates
(p#0.001) (Figure 8E, Movie S3). Lower U0126 concentrations
had more subtle but still significant effect; after 96 h, 26% (p#
0.01) and 35.5% (p#0.001) of adult worms separated, and 44.7%
(p#0.001) and 29% (p#0.01) of males detached from plates with
5 mM and 20 mM U0126, respectively (Figures 8A, 8E). With
20 mM U0126 egg output declined at 24 h but increased between
24 and 48 h (p#0.01) (Figure 8C). This early suppression of
oviposition is interesting given that activated ERK was observed in
the seminal receptacle, uterus, ootype region and Mehlis’ gland.
Egg production essentially ceased at 50 mMU0126 with only a few
(2–3) small immature eggs sporadically found, possibly a conse-
quence of worm separation (Figure 8C). U0126 also affected worm
motion. At 1 h, 1, 5, 20 or 50 mM U0126 increased tip velocity
(when worms were paired) by 265% (to 9.37 mm/s; p#0.001),
203% (to 7.62 mm/s; p#0.01), 251% (to 8.87 mm/s; p#0.001)
and 285% (to 10.66 mm/s (p#0.001), respectively, compared to
DMSO control speeds of 3.54 mm/s. However, movement
decreased temporally and at 96 h velocities were between 3.17
and 5.85 mm/s (Figure 9B). Because worms separated rapidly in
50 mM U0126, tip velocities for the resultant unpaired worms
were also determined for the remainder of the assay while in the
inhibitor. These single males and females displayed high posterior
tip velocities after 1 h with speeds of 9.74 and 8.5 mm/s,
respectively (Figure 9D, 9F); thereafter, movement decreased
and at 96 h males were 50% and females 90% slower. An
uncoordinated ‘jerky’ behavior was observed at all U0126 doses
(Movie S3).
GF109203X inhibited worm pairing, egg output, and ventral
sucker attachment (Figure 8B, 8D, 8F) and also induced extensive
and persistent worm coiling (Figure 10; Movie S4). During the first
hour, a proportion of worms remained paired at all GF109203X
concentrations, and at .1 mM pairs coiled persistently which
seemed to be caused by males, sometimes resulting in expulsion of
female gut contents (Movies S4 and S5). After 1 h in 20 mM
GF109203X, 94% of males had detached from plates (p#0.001)
(Figure 8F). Between 24 h and 96 h all worms separated in 50 mM
GF109203X, with separation also observed at lower concentra-
tions (p#0.001) (Figure 8B). Egg output was also completely
blocked within 24 h (Figure 8D) with 20 mM or 50 mM
GF109203X (p#0.001) (Figure 8D). This reduction in egg output
was sustained over 96 h despite couples remaining. This could be
due to PKC inhibition affecting uterine muscular movement as
proposed for PKA [60], or to direct effects on egg fertilization/
formation. In the context of coiling, although worms displaying
three coils or more were most prevalent during the initial 48 h
GF109203X treatment (Figure 10) worms had an increased
propensity to coil throughout the experiment. For instance after
1 h in 5, 20 or 50 mM GF109203X only 52%, 26% and 30%
worms exhibited their normal shape, respectively (p#0.001), with
the remainder possessing one or more sustained coils (Figure 10B).
Worm tip velocity of couples was inhibited by 50 mMGF109203X
only, to 1.9 mm/s (p#0,001) or 60% that of controls (Figure 9A).
However after worms separated in response to GF109203X
movement reduced, with striking effects seen at 96 h (p#0,001)
when the single males displayed velocities of just 0.06 mm/s and
Figure 6. Immunolocalization of phosphorylated (activated) PKC in intact S. mansoni. Adult worm pairs were either (A–K) fixed
immediately after perfusion, or (L–O) treated with PMA (1 mM; 15 min) before fixing. Worm pairs were then incubated with anti-phospho PKC (pan) (f
Thr410) or anti-phospho PKC (pan) (bII Ser660) primary antibodies (Ab) and Alexa Fluor 488 secondary antibodies (green); specimens were
additionally stained with rhodamine phalloidin to reveal actin filaments (red). Activated PKC was found associated with: (B, C, I, N) oesophagus (OE)
and oesophageal gland (OG); (A, D, F, G, J–L) tubercles (T) of the tegument (TT); (E, M) reproductive structures including the uterus (UT) surrounding
an egg (EG) during expulsion and lumen of the vitellaria (LV); (K) longitudinal (LM) and circular muscle (CM) layers; (F,G) myocytons (MC) including
those close to the (H) ventral sucker (VS); (O) the VS; and (F,G) the neural plexus (NP) innervating the musculature (MU). (L) The asterisk (*) identifies
an area of the tegument possibly disrupted by PMA. All images are of z-axis projections displayed in maximum pixel brightness mode. Bar:
A = 100 mM, B–O= 50 mm.
doi:10.1371/journal.pntd.0002924.g006
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Figure 7. Immunolocalization of phosphorylated (activated) ERK in intact S. mansoni. Adult worm pairs were either (A–H) fixed
immediately after perfusion, or (I–M) treated with PMA (1 mM; 15 min) before fixing. Worm pairs were then incubated in anti-phospho p44/42 MAPK
(ERK1/2) (Thr202/Tyr204) antibodies and Alexa Fluor 488 secondary antibodies (green); specimens were additionally stained with rhodamine
phalloidin to reveal actin filaments (red). Under normal conditions activated ERK was found associated with: (A, B) flame cells (FC) and excretory
tubules (ET); (C) oesophagus (OE); (D) tubercles (T) of the tegument (TT); (E) seminal receptacle (SR) adjacent to the ovary (OV); (F) the uterus (UT)
surrounding an egg (EG) during expulsion; (G, H) the region of the Mehlis’ gland (MG) adjacent to the ootype (OT) containing the egg. Following
exposure to PMA increased ERK activation was evident over (I) the worm surface including at the (J) ventral sucker (VS), and (K) the tubercles (T) of the
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0.09 mm/s, and the single females 0.3 mm/s and 0.17 mm/s for
20 mM and 50 mM GF109203X, respectively (Figures 9C, 9E;
Movie S4).
PMA (1 mM) also induced rapid worm separation and only 10%
remained paired at 24 h (p#0.001) and none at 48 h (Figure 8B;
Movie S6). At least 75% of worms detached from plates after 24 h
tegument (TT). Activated ERK was also associated with (L) the testicular lobes (TL) and (M) the ovary (OV). All images are of z-axis projections
displayed in maximum pixel brightness mode. Bar: = 50 mm.
doi:10.1371/journal.pntd.0002924.g007
Figure 8. Modulation of PKC and ERK activity in adult S. mansoni induces worm uncoupling, suppresses egg output, and causes
male worms to detach. Adult worm pairs were incubated in increasing concentrations of U0126, GF109203X, or 1 mM PMA and movies captured at
various time points over 96 h and imported into Image J. The effects of these compounds on (A, B) pairing, (C, D) egg release by paired worms
(uncoupled worms were not included), and (E, F) male adult worm detachment from the culture plate were then determined against vehicle controls
(which in A–D were assigned a value of 100% and are shown as the dotted line). Mean values (6 SEM) shown represent those from four independent
experiments, each of which contained a minimum of six adult worm pairs. *p#0.05, **p#0.01, and ***p#0.001 (ANOVA).
doi:10.1371/journal.pntd.0002924.g008
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rising to over 97% after 96 h. Initially, the separated males showed
reduced movement in PMA and separated female velocities were
similar to those of remaining control pairs, however, over time the
male worm tip velocities increased to 5.3 mm/s (Figure 9C). No
eggs were produced in PMA by worms (Figure 8D), persistent
coiling was absent and worms appeared rigid, although this
became less prominent over time (data not shown).
Blair et al. [20] first alluded to a role for PKC in S. mansoni
muscle contraction. Our detailed analyses substantiate this role,
and link aberrant phenotypes induced by disrupted signalling to
Figure 9. Modulation of PKC and ERK activity in adult S. mansoni affects worm movement. Adult worm pairs were incubated with
increasing concentrations of U0126, GF109203X, or 1 mM PMA and movies captured at various time points over 96 h and imported into Image J.
Movies were then analyzed to determine the speed of movement (velocity, mm/s) that the posterior tip of each worm travelled in 10 s when (A, B)
coupled. In some cases worms uncoupled as a consequence of treatment (as shown in Figure 8A, B). When this was the case, the speed of movement
of the uncoupled (C, D) single male or (E, F) female worms was determined for their respective treatments for the remainder of the assay; note that no
vehicle control exists when worms had separated because the control worms remained paired. Mean values (6 SEM) shown represent those from
four independent experiments each of which contained a minimum of six adult worm pairs; the actual numbers of worms in each analysis is,
however, dependent upon the uncoupling effect of the individual treatment (shown in Figures 8A, B). *p#0.05, **p#0.01, and ***p#0.001 (ANOVA).
doi:10.1371/journal.pntd.0002924.g009
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anatomical findings for activated PKC (and ERK) identified using
functional kinase mapping. Extensive labelling of activated PKC in
the muscle with activation also apparent in the neural plexus and
myocytons is in accordance with effects of PKC modulation on
worm motility, coiling and male ventral sucker detachment. PKCs,
particularly PKCb, mediate smooth muscle contraction in
vertebrates [68,69], and, in C. elegans, PKCa/PKCb-like PKC2
isotypes are expressed in neurons and muscle cells [40]. In
addition, PKC inhibitors block FMRF-amide induced muscle
contraction in S. mansoni [70]. Despite having opposing effects on
PKC phosphorylation, PMA and the higher doses of
GF1090203X affected ventral sucker attachment and worm
pairing similarly over 96 h (Figures 8B, 8D, 8F) and tip velocity
within the initial 24 h (Figures 9A, 9C, 9E); however, PMA did not
induce coiling. Although PMA activates PKC, overnight phorbol
ester treatment is used to down-regulate cPKC expression in
mammalian cells [71]. Therefore, we exposed live adult worm
pairs to PMA (1 mM) for 24 h. Western blotting with anti-phospho
Figure 10. Modulation of PKC activity in adult S. mansoni induces sustained coiling. Adult worm pairs were incubated with increasing
concentrations of GF109203X, or 1 mM PMA and movies captured at (B) 1 h, (C) 24 h, (D) 48 h, (E) 72 h, and (F) 96 h and imported into Image J.
Movies were then analyzed to determine the number of coils (shown in A) present per worm that were sustained for at least 10 s. Values shown
represent the mean (6 SEM) percentage of worms displaying a given number of coils at each time point for each treatment. *p#0.05, **p#0.01, and
***p#0.001 (ANOVA).
doi:10.1371/journal.pntd.0002924.g010
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PKC (pan) (f Thr410) and anti-phospho PKC (pan) (bII Ser660)
antibodies revealed that such treatment suppressed activation of
PKCs to between 80% (60.06%; p#0.001, n= 3; for the
,132 KDa PKC) and 64% (60.1%; p#0.05, n=23; 116 kDa
PKC) (Figure S2). Although we could not ascertain whether PKC
protein expression was reduced, because we lacked an antibody
that satisfactorily detects total PKC protein levels, the significant
reduction in phosphorylation of treated worms demonstrates
pathway deactivation, the critical parameter in terms of function.
This information also suggests that decreased expression likely
occurred. Therefore, the effects of PMA treatment on worm
phenotype after 24 h might be expected to reflect those seen with
GF109203X, which they do in part. However, because PMA
causes tegumental disruption [61] stress-related effects on pheno-
type are possible. The role of ERK in schistosome muscle
contraction requires further investigation. Whereas MEK inhibi-
tion increased motility of worm pairs, motility of single females
reduced considerably over 72 h and was lower than that of single
males (Figures 9B, 9D, 9F). Nevertheless, that U0126 affected
worm motility, attachment and pairing, highlights the ERK
pathway, together with the PKC pathway, as an important
regulator of schistosome muscle homeostasis.
Praziquantel induces activation of S. mansoni PKCs and
ERKs
Because PZQ affects cellular calcium dynamics [72,73] and
cPKCs are calcium responsive [19] we hypothesized that PZQ
would affect the activation of S. mansoni PKCs and ERKs. After
15 min PZQ treatment, worm pairs became contracted and
immobile and assumed a shrunken appearance (data not shown);
coincident with this, the ,78, ,81, and ,132 kDa PKCs
detected with anti-phospho PKC (pan) (f Thr410) antibodies
showed increased phosphorylation (p#0.05; Figures 11A, 11B).
Although the ,116 kDa PKC detected by anti-phospho PKC
(pan) (bII Ser 660) antibodies was unaffected by PZQ at 15 min,
increased phosphorylation was observed at 30 min and 120 min
(p#0.001; Figures 11A, 11B). The ,43 kDa ERK was also
activated in response to PZQ treatment displaying a 2.9-fold
increase in phosphorylation at 15 min (p#0.001; Figure 11A, 11B)
whereas the ,48 kDa ERK was less affected.
Confocal laser scanning microscopy revealed that PZQ-treated
worms possessed strong ERK and PKC activation, with generally
more signal in males than females (Figures 11C–K). Activated
ERK was associated with the tegument of paired male and female
worms, male sub-tegumental regions, musculature, and cephalic
ganglia on the male head (Figures 11G–K). Anti-phospho PKC
(pan) (f Thr410) antibodies revealed activated PKC associated
with tegumental and subtegumental regions, the oral sucker and
oesophagus and structures along the dorsal side of male and
female worms resembling collecting ducts (Figures 11C–F) which
were also faintly seen in some PMA treatments (data not shown).
The pattern of activation revealed using anti-phospho PKC (pan)
(bII Ser 660) antibodies was similar that in the absence of PZQ,
however, low levels of PKC activation were also seen in the
testicular lobes (data not shown).
Despite decades of use the precise action of PZQ remains
unresolved. Adult worms exposed to PZQ become paralyzed, lose
ion homeostasis and take up calcium [72–74]; tegument disruption
ensues with an associated exposure of worm antigens at the surface
[75]. Mature males are more sensitive towards PZQ than females;
additionally juvenile 28-day old worms, which are refractory to
PZQ, take up large quantities of calcium, implying that PZQ
sensitivity is not entirely due to calcium influx [39]. Possible targets
of PZQ include a Cavb ion channel subunit [76], myosin light
chain [77] and actin [78]. Sustained worm contraction typical of
PZQ treatment was observed here when worms were exposed to
PMA for 1 h (Figure 9A); thus, PZQs affect on worm motility is
likely mediated through PKC and ERK. Interestingly, 28-day old
worms exposed to PZQ for 20 h displayed a 6-fold increase in the
gene coding for a suppressor of MEK [79]; this could serve to
dampen PZQ-dependent ERK activation. Moreover, recently,
PKC expression was found to be upregulated in adult male and
female S. japonicum when exposed in vivo to a sub-lethal PZQ dose
for 12 h or more, possibly in response to the increased calcium
influx [80]. Therefore, whether the activation of PKC and/or
ERK influences the outcome of worm survival in the face of PZQ
treatment should be further investigated.
Conclusions and context for schistosome control
To conclude, we have, for the first time, functionally
characterised global signalling by PKCs and ERKs in adult S.
mansoni and, using functional mapping, have localized PKC and
ERK activities to numerous anatomical regions important to
schistosome motor activity, excretion, reproduction and host-
parasite interactions. Detailed phenotypic analysis has revealed
that these kinases perform a role in adult worm movement,
attachment, pairing and oviposition with pairing, worm tip
velocity, ventral sucker attachment, and egg output reduced.
Some of these outcomes (e.g., muscular movement and oviposi-
tion) might be interconnected. Intracellular signal transduction is
complex and signalling pathways are also interconnected. There-
fore, while it is possible that some of the observed phenotypic
effects might result from indirect effects of kinase inhibition on
associated pathways/mechanisms, the results of this paper indicate
that PKCs and ERKs play an important role. Nevertheless, a goal
of future research would be to define the importance of any
indirect mechanisms on these phenotypes. Exploiting existing anti-
cancer drugs that target protein kinases for the control of human
Figure 11. Praziquantel (PZQ) induces the phosphorylation (activation) of ERK and PKC in adult S. mansoni. (A) Live adult worms were
exposed to 0.02 mg/ml PZQ or 0.2% DMSO (vehicle control) for 15, 30 and 120 min. Proteins (12 mg) were processed for Western blotting and blots
probed with anti-phospho PKC (pan) (f Thr410), anti-phospho PKC (pan) (bII Ser660), or anti-phospho p44/42 MAPK (ERK1/2) (Thr202/Tyr204)
antibodies (Ab); anti-actin antibodies were used to assess protein loading differences between samples. (B) Immunoreactive bands from three
independent experiments, each with two replicates, were analyzed and mean relative change (6 SEM) in phosphorylation for each protein calculated
relative to the phosphorylation of controls that were assigned a value of 1 (shown as the dotted line). *p#0.05, **p#0.01, and ***p#0.001 (ANOVA).
(C–K) Adult worm pairs were treated with 0.02 mg/ml PZQ for 15 min prior to fixing. Worm pairs were then incubated in either (C–F) anti-phospho
PKC (pan) (f Thr410) or (G–K) anti-phospho p44/42 MAPK (ERK1/2) (Thr202/Tyr204) primary antibodies, followed by Alexa Fluor 488 secondary
antibodies (green); specimens were also stained with rhodamine phalloidin to show actin filaments (red). Activated PKC was found particularly
associated with: (C) the tegument (TT) and oesophagus (OE); (C, F) opening of the oral sucker (OS) and myocytons (MC); (D) the musculature of the
ventral sucker (VS); and (C–E) collecting ducts of the excretory system (arrowed). Activated ERK was found particularly associated with (G, I) tubercles
(T) of the tegument (TT); (H) cephalic ganglia (arrowed); (J) musculature (arrow); and (K) surface of the female worm tegument (TT) adjacent to the
male gynaecophoric canal. All microscopy images are of z-axis projections displayed in maximum pixel brightness mode Bar: C, D, G, K = 100 mm; E, F,
H, I = 25 mm.
doi:10.1371/journal.pntd.0002924.g011
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parasites is an attractive approach, one that has been proposed
previously for schistosomes [16]. Ras-Raf-MEK-ERK signalling
represents a potential target in cancer therapy and several small
molecule inhibitors of this pathway are being tested in clinical
trials [81]. The PKC pathway also represents a potential target
[82,83]. Moreover, the insulin receptor, which signals through to
PKC and ERK pathways has been proposed recently to be a
viable vaccine target against schistosomes [84,85]. Therefore,
given the effects of global PKC and ERK inhibition on
schistosome homeostasis and egg production, we propose that
these pathways, including specific isotype analysis and isotype
knockdown by RNAi, are investigated further as they represent
potential anti-schistosome drug targets. Currently, we are studying
PKC and ERK pathways in schistosomules, a stage that is PZQ-
insensitive, to appreciate signalling by these kinases during host-
parasite interactions and during early schistosome development in
the human host.
Supporting Information
Figure S1 Negative control for confocal microscopy.
Representative confocal microscopy image of S. mansoni adult
worm pair incubated with Alexa Fluor 488 secondary antibody
(green) and rhodamine phalloidin (red) but not incubated in
primary antibody. (A) red channel revealing actin staining and
(B) green channel demonstrating lack of fluorescence in the
absence of primary antibody. In each experiment a negative
control was prepared to calibrate laser power and gain
intensities, which were then kept constant for all observations.
Images are of z-axis projections displayed in maximum pixel
brightness mode.
(TIF)
Figure S2 Long-term PMA exposure decreases PKC
activation in adult S. mansoni. Detection of phosphorylated
(activated) S. mansoni PKCs after live adult worm pairs were
exposed to 1 mM PMA or DMSO vehicle for 24 h. Protein
homogenates (20 mg) were processed for Western blotting and
blots probed with anti-phospho PKC (pan) (f Thr410) and anti-
phospho PKC (pan) (bII Ser660) antibodies (Abs) in combination.
Anti-actin antibodies were used to assess protein loading between
samples. The blots shown are representative of those obtained
from three experiments.
(TIF)
Figure S3 Predicted PKCs in S. mansoni and tentative
assignment of observed immunoreactive PKCs to Smp
identifiers. The relative gene expression data for cercariae (C),
3 h and 24 h schistosomules (3 h S and 24 h S), and adult worms
(A) were extracted from GeneDB (www.genedb.org) [50].
(TIF)
Movie S1 Control S. mansoni. Adult worms were main-
tained in RPMI 1640 and were filmed after 1, 24, 48, 72, and
96 h.
(AVI)
Movie S2 Inhibition of ERK induces separation of S.
mansoni couples. Adult worms were incubated in 50 mM
U0126 and were filmed after 30 min.
(AVI)
Movie S3 Inhibition of ERK induces separation of S.
mansoni couples, reduces ventral sucker attachment,
and affects worm motility. Adult worms were incubated in 1,
5, 20 or 50 mM U0126 and were filmed after 1, 24, 48, 72 and
96 h.
(AVI)
Movie S4 Inhibition of PKC induces separation of S.
mansoni couples, reduces ventral sucker attachment,
affects worm motility, and increases worm coiling. Adult
worms were incubated in 1, 5, 20 or 50 mMGF109203X and were
filmed after 1, 24, 48, 72 and 96 h.
(AVI)
Movie S5 Expulsion of blood from female S. mansoni in
copula with a male. Adult worms were treated with 20 mM
GF109203X and were filmed at 1 h. Here the increased and
sustained worm coiling likely caused blood to be expelled from the
female worm.
(AVI)
Movie S6 PMA induces separation of S. mansoni
couples, reduces ventral sucker attachment, and affects
wormmotility. Adult worms were incubated in 1 mM PMA and
were filmed after 1, 24, 48, 72 and 96 h.
(AVI)
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